FDA Inspection 990270 — NewYork-Presbyterian/Weill Cornell Medical Center

NewYork-Presbyterian/Weill Cornell Medical Center — FEI 2470926

The FDA completed an inspection of NewYork-Presbyterian/Weill Cornell Medical Center on October 28, 2016 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 28, 2016
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)